skip to content
Home

Centre for Misfolding Diseases

Dr Maria Vias Lopez

MPACC Laboratory Manager

Publications

Guidelines for the use of cell lines in biomedical research.
RJ Geraghty, A Capes-Davis, JM Davis, J Downward, RI Freshney, I Knezevic, R Lovell-Badge, JRW Masters, J Meredith, GN Stacey, P Thraves, M Vias, Cancer Research UK
– Br J Cancer
(2014)
111,
1021
(doi: 10.1038/bjc.2014.166)
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network
A Ramos-Montoya, AD Lamb, R Russell, T Carroll, S Jurmeister, N Galeano-Dalmau, CE Massie, J Boren, H Bon, V Theodorou, M Vias, GL Shaw, NL Sharma, H Ross-Adams, HE Scott, SL Vowler, WJ Howat, AY Warren, RF Wooster, IG Mills, DE Neal
– EMBO Molecular Medicine
(2014)
6,
651
(doi: 10.1002/emmm.201303581)
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network
A Ramos-Montoya, AD Lamb, R Russell, T Carroll, S Jurmeister, N Galeano-Dalmau, CE Massie, J Boren, H Bon, V Theodorou, M Vias, GL Shaw, NL Sharma, H Ross-Adams, HE Scott, SL Vowler, WJ Howat, AY Warren, RF Wooster, IG Mills, DE Neal
– EMBO molecular medicine
(2014)
6,
651
(doi: 10.1002/emmm.201303581)
C-MYC induction of Hes6 activates a distinct transcriptional network driving androgen insensitive prostate cancer
ADG Lamb, A Ramos-Montoya, M Vias, H Scott, IG Mills, DE Neal
– BJU INTERNATIONAL
(2011)
108,
31
(link to publication)
C-MYC induction of HES6 activates a distinct transcriptional network driving androgen insensitive prostate cancer
A Lamb, A Ramos-Montoya, M Vias, H Scott, I Mills, D Neal
– BRITISH JOURNAL OF SURGERY
(2011)
98,
15
(link to publication)
Investigating the role for c-myc and bHLH transcription factors in driving phenotypic versatility of cancer stem cells in castrate resistant prostate cancer
AD Lamb, A Ramos-Montoya, M Vias, I Mills, DE Neal
– BJU INTERNATIONAL
(2010)
106,
53
(link to publication)
Terminal and progenitor lineage-survival oncogenes as cancer markers.
M Vias, A Ramos-Montoya, IG Mills
– Trends Mol Med
(2008)
14,
486
(doi: 10.1016/j.molmed.2008.09.002)
Pro-neural transcription factors as cancer markers.
M Vias, CE Massie, P East, H Scott, A Warren, Z Zhou, AY Nikitin, DE Neal, IG Mills
– BMC Medical Genomics
(2008)
1,
17
(doi: 10.1186/1755-8794-1-17)
LYRIC, a novel modulator of Wnt/fO-catenin and androgen receptor signalling in prostate cancer
D Neal, H Whitaker, I Mills, M Vias
– BJU INTERNATIONAL
(2008)
101,
32
(link to publication)
A role for neurotensin in bicalutamide resistant prostate cancer cells
D Neal, M Vias, I Mills
– BJU INTERNATIONAL
(2008)
101,
32
(link to publication)
  • <
  • 2 of 3
  • >

Support staff

Telephone number

01223 760880

Email address

College

Clare College

    Study at Cambridge

    About the University

    Research at Cambridge